EN ES CAT
Aromics
  • Home
  • About
    About us Our Team Funding
  • Research
    Internal R&D Collaborative R&D Partnerships
  • Projects
    Ongoing Projects Finalized Projects
  • Products
    Strategy Therapeutic Pipeline
  • Careers
  • Newsroom
    News Events Media
  • Contact

  1. Home
  2. Newsroom
  3. Media

Media

2021

09|02

TOP 2021 companies: the CEO of AROMICS among the most outstanding professionals in business

Detail of the short interview with Dr. Carmen Plasencia, CEO and co-founder of AROMICS. The interview published last June 27, 2021 in the weekly supplement of Empresa of the ABC newspaper, allows readers to understand the main keys of the developments...
  read whole news

TOP 2021 companies: the CEO of AROMICS among the most outstanding professionals in business

2021

02|14

Biotechnology and COVID impact_ AROMICS

  see details

Biotechnology and COVID impact_ AROMICS

2019

08|1

Using ‘Omics’ to Develop Treatments for Drug-Resistant Cancer

  see details

Using ‘Omics’ to Develop Treatments for Drug-Resistant Cancer

2019

08|25

Copying Asbestos Legacy

  see details

Copying Asbestos Legacy

1919

02|14

AROMICS develops a novel therapy for malignant mesothelioma

  see details

AROMICS develops a novel therapy for malignant mesothelioma

2019

02|13

AROMICS receives 1 Million Euros to advance in its therapy for cancer

  see details

2019

02|13

AROMICS receives 1 Million Euros to advance in its therapy for cancer

  see details

AROMICS receives 1 Million Euros to advance in its therapy for cancer

2018

03|21

AMMIC: New platform for Catalan companies and organizations accelerates drug R&D for minority diseases

  see details

2017

12|17

Asbestos and cancer

  see details

Asbestos and cancer
ACC10
FEDER
Neotec
Enisa
European Commission
Innovative SME
European Union
ICF logo
FP6 logo
FP7 logo
MICIN logo
European EC H2020
EIT health logo
Fondo resiliencia
Next generation EU
CDTI logo
  • Contact
  • Newsroom
  • Web map
©2019 Applied Research using Omics Sciences.
All rights reserved.
Private Area  |  Terms of use  |  Privacy policy